|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US6455677B1
(en)
|
1998-04-30 |
2002-09-24 |
Boehringer Ingelheim International Gmbh |
FAPα-specific antibody with improved producibility
|
|
US6465181B2
(en)
|
1999-03-25 |
2002-10-15 |
Abbott Laboratories |
Reagents and methods useful for detecting diseases of the prostate
|
|
CA2372119A1
(en)
|
1999-05-17 |
2000-11-23 |
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Und Zum Vertrie B Von Pharmaka Mbh |
Neuroprotective properties of gdf-15, a novel member of the tgf-.beta. superfamily
|
|
US7141661B2
(en)
|
2000-09-08 |
2006-11-28 |
The United States Of America As Represented By The Department Of Health And Human Services |
Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
|
|
ES2689328T3
(es)
|
2004-01-07 |
2018-11-13 |
Novartis Vaccines And Diagnostics, Inc. |
Anticuerpo monoclonal M-CSF-específico y usos del mismo
|
|
DK2441466T3
(da)
|
2004-04-13 |
2014-10-27 |
St Vincents Hosp Sydney |
MIC-1-inhiberende middel
|
|
US20070128636A1
(en)
|
2005-12-05 |
2007-06-07 |
Baker Joffre B |
Predictors Of Patient Response To Treatment With EGFR Inhibitors
|
|
US20100278843A1
(en)
|
2007-08-16 |
2010-11-04 |
St. Vincent's Hospital Sydney Limited |
Agents and methods for modulating macrophage inhibitory cytokine (mic-1) activity
|
|
CN101896192A
(zh)
|
2007-10-09 |
2010-11-24 |
圣文森特医院悉尼有限公司 |
一种通过去除或灭活巨噬细胞抑制因子-1而治疗恶病质的方法
|
|
WO2009150256A1
(en)
|
2008-06-13 |
2009-12-17 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Markers for predicting response and survival in anti-egfr treated patients
|
|
CA2737636A1
(en)
|
2008-09-29 |
2010-04-01 |
Roche Glycart Ag |
Antibodies against human il17 and uses thereof
|
|
CA2737597C
(en)
|
2008-10-16 |
2017-03-14 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
|
|
EP2209003A1
(en)
|
2009-01-16 |
2010-07-21 |
F. Hoffmann-Roche AG |
Means and methods for differentiating between fibrosis and cirrhosis
|
|
US7736861B1
(en)
|
2009-10-19 |
2010-06-15 |
Aveo Pharmaceuticals, Inc. |
Tivozanib response prediction
|
|
US20120309697A1
(en)
|
2009-10-28 |
2012-12-06 |
Samuel Norbert Breit |
Methods of diagnosing and prognosing colonic polyps
|
|
US9212221B2
(en)
|
2010-03-03 |
2015-12-15 |
Detroit R & D, Inc. |
Form-specific antibodies for NAG-1 (MIC-1, GDF-15), H6D and other TGF-β subfamily and heart disease and cancer diagnoses
|
|
KR20130043104A
(ko)
|
2010-04-06 |
2013-04-29 |
카리스 라이프 사이언스 룩셈부르크 홀딩스 |
질병용 순환 생물학적 지표들
|
|
EP2388594A1
(en)
|
2010-05-17 |
2011-11-23 |
Roche Diagnostics GmbH |
GDF-15 based means and methods for survival and recovery prediction in acute inflammation
|
|
CN105859889B
(zh)
|
2010-11-17 |
2020-01-07 |
中外制药株式会社 |
具有代替凝血因子viii的功能的功能的多特异性抗原结合分子
|
|
EP2506015A1
(en)
|
2011-04-01 |
2012-10-03 |
Universität Regensburg |
A prognostic and therapeutic signature for malignant melanoma
|
|
DK2714738T3
(en)
|
2011-05-24 |
2019-01-28 |
Zyngenia Inc |
MULTIVALENT AND MONOVALENT MULTISPECIFIC COMPLEXES AND THEIR APPLICATIONS
|
|
WO2013012648A1
(en)
|
2011-07-15 |
2013-01-24 |
Emory University |
Gdf15 in diagnostic and therapeutic applications
|
|
US8790651B2
(en)
|
2011-07-21 |
2014-07-29 |
Zoetis Llc |
Interleukin-31 monoclonal antibody
|
|
CN102321173B
(zh)
|
2011-08-12 |
2013-04-03 |
中国医学科学院肿瘤研究所 |
人源化巨噬细胞抑制因子1单克隆抗体及其应用
|
|
EP2565262A1
(en)
|
2011-08-31 |
2013-03-06 |
VTU Holding GmbH |
Protein expression
|
|
KR20140125803A
(ko)
|
2012-01-26 |
2014-10-29 |
암젠 인크 |
성장 분화 인자 15(gdf-15) 폴리펩타이드들
|
|
AU2013322628B2
(en)
|
2012-09-26 |
2017-03-02 |
Julius-Maximilians-Universitat Wurzburg |
Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)
|
|
ES3066738T3
(en)
|
2012-12-21 |
2026-05-14 |
Aveo Pharmaceuticals Inc |
Anti-gdf15 antibodies
|
|
US11021752B2
(en)
|
2013-03-15 |
2021-06-01 |
Myriad Genetics, Inc. |
Genes and gene signatures for diagnosis and treatment of melanoma
|
|
WO2015108907A2
(en)
|
2014-01-14 |
2015-07-23 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for identification, assessment, prevention, and treatment of melanoma using pd-l1 isoforms
|
|
ES2712201T3
(es)
|
2014-01-28 |
2019-05-09 |
Hoffmann La Roche |
Biomarcadores para la evaluación de riesgos y la monitorización del tratamiento en pacientes de insuficiencia cardíaca que han recibido terapia guiada por el péptido natriurético de tipo B
|
|
PT3134123T
(pt)
|
2014-02-21 |
2021-03-22 |
Nektar Therapeutics India Pvt Ltd |
Agonistas seletivos de il-2rbeta em combinação com um anticorpo anti-ctla-4 ou um anticorpo anti-pd-1
|
|
PT3653644T
(pt)
|
2014-03-26 |
2023-12-19 |
Univ Wuerzburg J Maximilians |
Anticorpos monoclonais do fator de crescimento e diferenciação 15 (gdf-15) e suas utilizações para o tratamento da caquexia cancerosa e do cancro
|
|
EP3851122A1
(en)
*
|
2014-09-25 |
2021-07-21 |
Aveo Pharmaceuticals Inc. |
Methods of reversing cachexia and prolonging survival comprising administering a gdf15 modulator and an anti-cancer agent
|
|
EP3073268A1
(en)
|
2015-03-27 |
2016-09-28 |
Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts |
Biomarker panel for diagnosing cancer
|
|
EP3356827B1
(en)
|
2015-10-02 |
2023-12-06 |
Julius-Maximilians-Universität Würzburg |
Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers
|
|
GB201517528D0
(en)
|
2015-10-02 |
2015-11-18 |
Julius Maximillians Universitãt Würzburg |
GDF-15 as a diagnosis marker for melanoma
|
|
KR102722730B1
(ko)
*
|
2015-10-02 |
2024-10-25 |
율리우스-막시밀리안스 우니버지태트 뷔르츠부르크 |
인간 증식 및 분화 인자 15 (gdf-15)의 저해제와 면역 체크포인트 차단제를 이용한 병용 요법
|
|
US11072657B2
(en)
|
2015-11-18 |
2021-07-27 |
Bristol-Myers Squibb Company |
Treatment of lung cancer using a combination of an anti-PD-1 antibody and an anti-CTLA-4 antibody
|
|
JP7138567B2
(ja)
*
|
2016-04-27 |
2022-09-16 |
ノバルティス アーゲー |
成長分化因子15に対する抗体およびそれらの使用
|
|
CN112912395B
(zh)
|
2018-08-20 |
2024-08-23 |
辉瑞公司 |
抗gdf15抗体、组合物和使用方法
|
|
US20230212274A1
(en)
|
2020-02-21 |
2023-07-06 |
The Children's Medical Center Corporation |
Method for treating asthma or allergic disease
|
|
CN114560938B
(zh)
|
2020-03-30 |
2023-05-23 |
中国人民解放军第四军医大学 |
抗gdf15中和性单克隆抗体及其应用
|
|
LT4243928T
(lt)
|
2020-11-10 |
2026-06-10 |
Catalym Gmbh |
Anti-gdf15 antikūnas ir dozavimo režimas, skirtas vėžio gydymui
|